Meclizine HCl
Meclizine HCl is an FDA drug label for the active ingredient MECLIZINE HYDROCHLORIDE manufactured by BluePoint Laboratories administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231117.
Generic: MECLIZINE HYDROCHLORIDE
Manufacturer: BluePoint Laboratories
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 68001-528
Application: M009
Effective: 20231117
Active Ingredients: Drug Facts Active ingredient (in each tablet) Meclizine HCl, USP 12.5 mg
Indications & Usage
Uses prevents and treats nausea, vomiting or dizziness associated with motion sickness.
Dosage & Administration
Directions dosage should be taken one hour before travel starts adults and children 12 years and over take 2 or 4 tablets once daily or as directed by a doctor
Contraindications
Not available.
Warnings
Warnings Do not use in children under 12 years of age unless directed by a doctor.
Adverse Reactions
Not available.
More from same ingredient
MECLIZINE HYDROCHLORIDE
Proficient Rx LP
MECLIZINE HYDROCHLORIDE
Bryant Ranch Prepack
Meclizine Hydrochloride
A-S Medication Solutions
Meclizine Hydrochloride
Proficient Rx LP
Meclizine Hydrochloride
A-S Medication Solutions
Meclizine Hydrochloride
Proficient Rx LP
Meclizine Hydrochloride
Zydus Lifesciences Limited